{"id":"https://openalex.org/W3092223969","doi":"https://doi.org/10.1007/s11302-020-09724-z","title":"Caffeine has a dual influence on NMDA receptor\u2013mediated glutamatergic transmission at the hippocampus","display_name":"Caffeine has a dual influence on NMDA receptor\u2013mediated glutamatergic transmission at the hippocampus","publication_year":2020,"publication_date":"2020-10-06","ids":{"openalex":"https://openalex.org/W3092223969","doi":"https://doi.org/10.1007/s11302-020-09724-z","mag":"3092223969","pmid":"https://pubmed.ncbi.nlm.nih.gov/33025424","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7855183"},"language":"en","primary_location":{"id":"doi:10.1007/s11302-020-09724-z","doi":"https://doi.org/10.1007/s11302-020-09724-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11302-020-09724-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11302-020-09724-z.pdf","source":{"id":"https://openalex.org/S111106147","display_name":"Purinergic Signalling","issn_l":"1573-9538","issn":["1573-9538","1573-9546"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Purinergic Signalling","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://link.springer.com/content/pdf/10.1007/s11302-020-09724-z.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063410837","display_name":"Robertta Silva Martins","orcid":"https://orcid.org/0000-0002-7177-7226","observed_orcids":["https://orcid.org/0000-0002-7177-7226"]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]},{"id":"https://openalex.org/I161127581","display_name":"Universidade Federal Fluminense","ror":"https://ror.org/02rjhbb08","country_code":"BR","type":"education","lineage":["https://openalex.org/I161127581"]}],"countries":["BR","PT"],"is_corresponding":false,"raw_author_name":"Robertta S. Martins","raw_affiliation_strings":["Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","Laborat\u00f3rio de Neurofarmacologia, Departamento de Fisiologia e Farmacologia, P\u00f3s-Gradua\u00e7\u00e3o em Neuroci\u00eancias, Universidade Federal Fluminense, Niter\u00f3i, Brazil"],"raw_orcid":"https://orcid.org/0000-0002-7177-7226","affiliations":[{"raw_affiliation_string":"Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","institution_ids":["https://openalex.org/I141596103"]},{"raw_affiliation_string":"Laborat\u00f3rio de Neurofarmacologia, Departamento de Fisiologia e Farmacologia, P\u00f3s-Gradua\u00e7\u00e3o em Neuroci\u00eancias, Universidade Federal Fluminense, Niter\u00f3i, Brazil","institution_ids":["https://openalex.org/I161127581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087044034","display_name":"Diogo M. Rombo","orcid":"https://orcid.org/0000-0002-9922-7381","observed_orcids":["https://orcid.org/0000-0002-9922-7381"]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]},{"id":"https://openalex.org/I4392738257","display_name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes","ror":"https://ror.org/019g8w217","country_code":"PT","type":"facility","lineage":["https://openalex.org/I141596103","https://openalex.org/I4392738257","https://openalex.org/I4405252639"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Diogo M. Rombo","raw_affiliation_strings":["Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal"],"raw_orcid":"https://orcid.org/0000-0002-9922-7381","affiliations":[{"raw_affiliation_string":"Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","institution_ids":["https://openalex.org/I141596103"]},{"raw_affiliation_string":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","institution_ids":["https://openalex.org/I141596103","https://openalex.org/I4392738257"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013341958","display_name":"Joana Gon\u00e7alves\u2010Ribeiro","orcid":"https://orcid.org/0000-0002-5194-6512","observed_orcids":["https://orcid.org/0000-0002-5194-6512"]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]},{"id":"https://openalex.org/I4392738257","display_name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes","ror":"https://ror.org/019g8w217","country_code":"PT","type":"facility","lineage":["https://openalex.org/I141596103","https://openalex.org/I4392738257","https://openalex.org/I4405252639"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Joana Gon\u00e7alves-Ribeiro","raw_affiliation_strings":["Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal"],"raw_orcid":"https://orcid.org/0000-0002-5194-6512","affiliations":[{"raw_affiliation_string":"Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","institution_ids":["https://openalex.org/I141596103"]},{"raw_affiliation_string":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","institution_ids":["https://openalex.org/I141596103","https://openalex.org/I4392738257"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012037255","display_name":"Carlos Meneses","orcid":"https://orcid.org/0000-0002-7770-7093","observed_orcids":["https://orcid.org/0000-0002-7770-7093"]},"institutions":[{"id":"https://openalex.org/I203847022","display_name":"Universidade Polit\u00e9cnica de Lisboa","ror":"https://ror.org/04ea70f07","country_code":"PT","type":"education","lineage":["https://openalex.org/I203847022"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Carlos Meneses","raw_affiliation_strings":["\u00c1rea Departamental de Engenharia de Electr\u00f3nica e Telecomunica\u00e7\u00f5es e de Computadores, Instituto Superior de Engenharia de Lisboa, Lisbon, Portugal"],"raw_orcid":"https://orcid.org/0000-0002-7770-7093","affiliations":[{"raw_affiliation_string":"\u00c1rea Departamental de Engenharia de Electr\u00f3nica e Telecomunica\u00e7\u00f5es e de Computadores, Instituto Superior de Engenharia de Lisboa, Lisbon, Portugal","institution_ids":["https://openalex.org/I203847022"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060944067","display_name":"Vladimir Pedro Peralva Borges-Martins","orcid":"https://orcid.org/0000-0002-5213-0363","observed_orcids":["https://orcid.org/0000-0002-5213-0363"]},"institutions":[{"id":"https://openalex.org/I161127581","display_name":"Universidade Federal Fluminense","ror":"https://ror.org/02rjhbb08","country_code":"BR","type":"education","lineage":["https://openalex.org/I161127581"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Vladimir P. P. Borges-Martins","raw_affiliation_strings":["Laborat\u00f3rio de Neurofarmacologia, Departamento de Fisiologia e Farmacologia, P\u00f3s-Gradua\u00e7\u00e3o em Neuroci\u00eancias, Universidade Federal Fluminense, Niter\u00f3i, Brazil"],"raw_orcid":"https://orcid.org/0000-0002-5213-0363","affiliations":[{"raw_affiliation_string":"Laborat\u00f3rio de Neurofarmacologia, Departamento de Fisiologia e Farmacologia, P\u00f3s-Gradua\u00e7\u00e3o em Neuroci\u00eancias, Universidade Federal Fluminense, Niter\u00f3i, Brazil","institution_ids":["https://openalex.org/I161127581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031806410","display_name":"Joaquim Alexandre Ribeiro","orcid":"https://orcid.org/0000-0002-9330-3507","observed_orcids":["https://orcid.org/0000-0002-9330-3507"]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]},{"id":"https://openalex.org/I4392738257","display_name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes","ror":"https://ror.org/019g8w217","country_code":"PT","type":"facility","lineage":["https://openalex.org/I141596103","https://openalex.org/I4392738257","https://openalex.org/I4405252639"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Joaquim A. Ribeiro","raw_affiliation_strings":["Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal"],"raw_orcid":"https://orcid.org/0000-0002-9330-3507","affiliations":[{"raw_affiliation_string":"Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","institution_ids":["https://openalex.org/I141596103"]},{"raw_affiliation_string":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","institution_ids":["https://openalex.org/I141596103","https://openalex.org/I4392738257"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027568151","display_name":"Sandra Henriques Vaz","orcid":"https://orcid.org/0000-0003-4258-9397","observed_orcids":["https://orcid.org/0000-0003-4258-9397"]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]},{"id":"https://openalex.org/I4392738257","display_name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes","ror":"https://ror.org/019g8w217","country_code":"PT","type":"facility","lineage":["https://openalex.org/I141596103","https://openalex.org/I4392738257","https://openalex.org/I4405252639"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Sandra H. Vaz","raw_affiliation_strings":["Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal"],"raw_orcid":"https://orcid.org/0000-0003-4258-9397","affiliations":[{"raw_affiliation_string":"Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","institution_ids":["https://openalex.org/I141596103"]},{"raw_affiliation_string":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","institution_ids":["https://openalex.org/I141596103","https://openalex.org/I4392738257"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028351201","display_name":"Regina C\u00e9lia Cussa Kubrusly","orcid":"https://orcid.org/0000-0002-6016-2197","observed_orcids":["https://orcid.org/0000-0002-6016-2197"]},"institutions":[{"id":"https://openalex.org/I161127581","display_name":"Universidade Federal Fluminense","ror":"https://ror.org/02rjhbb08","country_code":"BR","type":"education","lineage":["https://openalex.org/I161127581"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Regina C. C. Kubrusly","raw_affiliation_strings":["Laborat\u00f3rio de Neurofarmacologia, Departamento de Fisiologia e Farmacologia, P\u00f3s-Gradua\u00e7\u00e3o em Neuroci\u00eancias, Universidade Federal Fluminense, Niter\u00f3i, Brazil"],"raw_orcid":"https://orcid.org/0000-0002-6016-2197","affiliations":[{"raw_affiliation_string":"Laborat\u00f3rio de Neurofarmacologia, Departamento de Fisiologia e Farmacologia, P\u00f3s-Gradua\u00e7\u00e3o em Neuroci\u00eancias, Universidade Federal Fluminense, Niter\u00f3i, Brazil","institution_ids":["https://openalex.org/I161127581"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021255614","display_name":"Ana Maria Sebasti\u00e3o","orcid":"https://orcid.org/0000-0001-9030-6115","observed_orcids":["https://orcid.org/0000-0001-9030-6115"]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]},{"id":"https://openalex.org/I4392738257","display_name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes","ror":"https://ror.org/019g8w217","country_code":"PT","type":"facility","lineage":["https://openalex.org/I141596103","https://openalex.org/I4392738257","https://openalex.org/I4405252639"]}],"countries":["PT"],"is_corresponding":true,"raw_author_name":"Ana M. Sebasti\u00e3o","raw_affiliation_strings":["Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal. anaseb@medicina.ulisboa.pt","Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal. anaseb@medicina.ulisboa.pt","Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal"],"raw_orcid":"https://orcid.org/0000-0001-9030-6115","affiliations":[{"raw_affiliation_string":"Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal. anaseb@medicina.ulisboa.pt","institution_ids":["https://openalex.org/I141596103"]},{"raw_affiliation_string":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal. anaseb@medicina.ulisboa.pt","institution_ids":["https://openalex.org/I141596103","https://openalex.org/I4392738257"]},{"raw_affiliation_string":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal","institution_ids":["https://openalex.org/I141596103","https://openalex.org/I4392738257"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5021255614"],"corresponding_institution_ids":["https://openalex.org/I141596103","https://openalex.org/I4392738257"],"apc_list":{"value":3860,"currency":"USD","value_usd":3860},"apc_paid":null,"fwci":0.9451,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.66947952,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"16","issue":"4","first_page":"503","last_page":"518"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.02239999920129776,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11264","display_name":"Coffee research and impacts","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/caffeine","display_name":"caffeine","score":1.0},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.9449999928474426},{"id":"https://openalex.org/keywords/adenosine-receptors","display_name":"adenosine receptors","score":0.7929999828338623},{"id":"https://openalex.org/keywords/adenosine-a1-receptor","display_name":"adenosine A1 receptor","score":0.8939999938011169},{"id":"https://openalex.org/keywords/adenosine-a2a-receptor","display_name":"adenosine A2A receptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hippocampus","display_name":"hippocampus","score":0.7329999804496765},{"id":"https://openalex.org/keywords/ca1-pyramidal-neurons","display_name":"CA1 pyramidal neurons","score":0.9070000052452087},{"id":"https://openalex.org/keywords/excitatory-postsynaptic-currents","display_name":"excitatory postsynaptic currents","score":0.878000020980835},{"id":"https://openalex.org/keywords/paired-pulse-facilitation","display_name":"paired-pulse facilitation","score":0.8830000162124634},{"id":"https://openalex.org/keywords/neurotransmitter-release","display_name":"neurotransmitter release","score":0.7080000042915344},{"id":"https://openalex.org/keywords/neuronal-calcium-homeostasis","display_name":"neuronal calcium homeostasis","score":0.8980000019073486},{"id":"https://openalex.org/keywords/calcium-transients","display_name":"calcium transients","score":0.8330000042915344},{"id":"https://openalex.org/keywords/dpcpx","display_name":"DPCPX","score":0.7300000190734863},{"id":"https://openalex.org/keywords/sch58261","display_name":"SCH58261","score":0.949999988079071},{"id":"https://openalex.org/keywords/ap5","display_name":"AP5","score":0.5740000009536743},{"id":"https://openalex.org/keywords/adenosine-receptor-antagonists","display_name":"adenosine receptor antagonists","score":0.6449999809265137}],"concepts":[{"id":"https://openalex.org/C2778500429","wikidata":"https://www.wikidata.org/wiki/Q60235","display_name":"Caffeine","level":2,"score":0.7683417797088623},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.7158928513526917},{"id":"https://openalex.org/C200170125","wikidata":"https://www.wikidata.org/wiki/Q969316","display_name":"Neurotransmission","level":3,"score":0.6517359018325806},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.6266792416572571},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.5986451506614685},{"id":"https://openalex.org/C112592302","wikidata":"https://www.wikidata.org/wiki/Q1207387","display_name":"Excitatory postsynaptic potential","level":3,"score":0.5681471824645996},{"id":"https://openalex.org/C182683403","wikidata":"https://www.wikidata.org/wiki/Q14888579","display_name":"Adenosine A1 receptor","level":5,"score":0.5659107565879822},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5622259974479675},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.5484418272972107},{"id":"https://openalex.org/C2780634109","wikidata":"https://www.wikidata.org/wiki/Q18350222","display_name":"Adenosine receptor antagonist","level":5,"score":0.5249038934707642},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44030874967575073},{"id":"https://openalex.org/C115955781","wikidata":"https://www.wikidata.org/wiki/Q6063798","display_name":"Ionotropic effect","level":4,"score":0.43824607133865356},{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.4358028173446655},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.40711909532546997},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38130685687065125},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30028632283210754},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.235749751329422},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1897205412387848},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.09360229969024658},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09014323353767395}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002110","descriptor_name":"Caffeine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005973","descriptor_name":"Glutamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019706","descriptor_name":"Excitatory Postsynaptic Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058915","descriptor_name":"Purinergic P1 Receptor Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1007/s11302-020-09724-z","doi":"https://doi.org/10.1007/s11302-020-09724-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11302-020-09724-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11302-020-09724-z.pdf","source":{"id":"https://openalex.org/S111106147","display_name":"Purinergic Signalling","issn_l":"1573-9538","issn":["1573-9538","1573-9546"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Purinergic Signalling","raw_type":"journal-article"},{"id":"pmid:33025424","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33025424","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Purinergic signalling","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7855183","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7855183/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Purinergic Signal","raw_type":"Text"},{"id":"pmh:oai:repositorio.ipl.pt:10400.21/12401","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10400.21/12401","pdf_url":null,"source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"},{"id":"pmh:oai:repositorio.ulisboa.pt:10451/47319","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10451/47319","pdf_url":null,"source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"}],"best_oa_location":{"id":"doi:10.1007/s11302-020-09724-z","doi":"https://doi.org/10.1007/s11302-020-09724-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11302-020-09724-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11302-020-09724-z.pdf","source":{"id":"https://openalex.org/S111106147","display_name":"Purinergic Signalling","issn_l":"1573-9538","issn":["1573-9538","1573-9546"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Purinergic Signalling","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1221422973","display_name":null,"funder_award_id":"E-26/201.599/2018","funder_id":"https://openalex.org/F4320322749","funder_display_name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro"},{"id":"https://openalex.org/G332237055","display_name":"Na procura do mecanismo de a\u00e7\u00e3o de um novo e seletivo f\u00e1rmaco antiepileptico","funder_award_id":"PTDC/MED-FAR/30933/2017","funder_id":"https://openalex.org/F4320334779","funder_display_name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia"}],"funders":[{"id":"https://openalex.org/F4320322749","display_name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","ror":"https://ror.org/03kk0s825"},{"id":"https://openalex.org/F4320334779","display_name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","ror":"https://ror.org/00snfqn58"},{"id":"https://openalex.org/F4320335254","display_name":"Horizon 2020","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3092223969.pdf","grobid_xml":"https://content.openalex.org/works/W3092223969.grobid-xml"},"referenced_works_count":76,"referenced_works":["https://openalex.org/W14748109","https://openalex.org/W75676917","https://openalex.org/W1554377252","https://openalex.org/W1601854110","https://openalex.org/W1703915293","https://openalex.org/W1900197601","https://openalex.org/W1924082254","https://openalex.org/W1945529017","https://openalex.org/W1951534204","https://openalex.org/W1965280907","https://openalex.org/W1969170402","https://openalex.org/W1981643341","https://openalex.org/W1984883847","https://openalex.org/W1987812421","https://openalex.org/W1991923529","https://openalex.org/W1993067636","https://openalex.org/W1994217011","https://openalex.org/W1998932777","https://openalex.org/W2005997117","https://openalex.org/W2010121960","https://openalex.org/W2017151582","https://openalex.org/W2018654901","https://openalex.org/W2018774395","https://openalex.org/W2020494041","https://openalex.org/W2024469932","https://openalex.org/W2024853882","https://openalex.org/W2027524763","https://openalex.org/W2037852973","https://openalex.org/W2044301280","https://openalex.org/W2046897353","https://openalex.org/W2047098181","https://openalex.org/W2055182433","https://openalex.org/W2061473590","https://openalex.org/W2066621581","https://openalex.org/W2069204309","https://openalex.org/W2071507060","https://openalex.org/W2075763294","https://openalex.org/W2080581682","https://openalex.org/W2084077930","https://openalex.org/W2094980758","https://openalex.org/W2095596429","https://openalex.org/W2097533515","https://openalex.org/W2099167075","https://openalex.org/W2106861254","https://openalex.org/W2109702923","https://openalex.org/W2112927743","https://openalex.org/W2124211004","https://openalex.org/W2135990734","https://openalex.org/W2136717001","https://openalex.org/W2139817708","https://openalex.org/W2142318961","https://openalex.org/W2145758516","https://openalex.org/W2149745361","https://openalex.org/W2158059993","https://openalex.org/W2161002250","https://openalex.org/W2223902046","https://openalex.org/W2230804329","https://openalex.org/W2290653158","https://openalex.org/W2314874570","https://openalex.org/W2385585873","https://openalex.org/W2472172082","https://openalex.org/W2557584921","https://openalex.org/W2595054512","https://openalex.org/W2606538969","https://openalex.org/W2627083958","https://openalex.org/W2758608092","https://openalex.org/W2772792042","https://openalex.org/W2777541397","https://openalex.org/W2808229106","https://openalex.org/W2811459126","https://openalex.org/W2887002105","https://openalex.org/W2890149467","https://openalex.org/W2938986801","https://openalex.org/W2945094215","https://openalex.org/W2951319142","https://openalex.org/W3007970232"],"related_works":["https://openalex.org/W2951319142","https://openalex.org/W2046897353","https://openalex.org/W2103714118","https://openalex.org/W2032922382","https://openalex.org/W2123649426","https://openalex.org/W2030749623","https://openalex.org/W2781794876","https://openalex.org/W2058184966","https://openalex.org/W7096638884","https://openalex.org/W4294944230"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2020-10-15T00:00:00"}